Future investigations examining the effects of long-term effects of intranasal oxytocin administration on behavior and cognition in severe mental illnesses, such as schizophrenia, should also explore oxytocin’s effects on metabolic measures in tandem. This evidence concerns the gene OXT and schizophrenia.